Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer

EBioMedicine(2020)10.1016/j.ebiom.2020.102860Source: DataRank Database

Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer is a research paper published in EBioMedicine (2020). On theSindex it has a DataRank of 2.3. It has been cited 60 times, with 50 citing works in its 1-hop citation network.

N/A

2.3DataRank · unranked

Scored on demand from live citation data

Open Access60 citations · 50 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (51 grants)Impact (FWCI 2.82)OA: goldTopics (68)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 27%Citation Network 73%

Base Score Contribution

0.617

From this paper's citation signal

Citation Network Contribution

1.7

From 41 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 50 citers.

The battle for prognosis at the invasive front of colorectal cancer
EBioMedicine202011 citations10 referencesContributes 0.248
Refining the ITBCC tumor budding scoring system with a “zero-budding” category in colorectal cancer
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin202132 citations15 referencesContributes 0.233
Use of Deep Learning to Evaluate Tumor Microenvironmental Features for Prediction of Colon Cancer Recurrence
Cancer Research Communications202415 citations25 referencesContributes 0.111
Deep learning quantified mucus-tumor ratio predicting survival of patients with colorectal cancer using whole-slide images
Precision Clinical Medicine202112 citations29 referencesContributes 0.088
Tumour budding – an additional prognostic factor in colorectal cancer survival
Polish Journal of Pathology20237 citations26 referencesContributes 0.080

Authors (26)

Juha P. Väyrynen ORCID,Jennifer Borowsky ORCID,David Papke ORCID,Kota Arima,Koichiro Haruki ORCID

Live enrichment

PubMed:32652320 PMC:PMC7347996 OpenAlex:https://openalex.org/W3041902060

Dana-Farber/Harvard Cancer Center

Grant: SU2C-AACR-DT22–17

National Institutes of Health

Grant: K07 CA188126

National Institutes of Health

Grant: K24 DK098311

National Institutes of Health

Grant: P01 CA55075

National Institutes of Health

Grant: P01 CA87969

National Institutes of Health

Grant: P50 CA127003

National Institutes of Health

Grant: R01 CA118553

National Institutes of Health

Grant: R01 CA137178

National Institutes of Health

Grant: R01 CA151993

National Institutes of Health

Grant: R01 CA169141

National Institutes of Health

Grant: R01 CA225655

National Institutes of Health

Grant: R01 CA248857

National Institutes of Health

Grant: R35 CA197735

National Institutes of Health

Grant: U01 CA167552

National Institutes of Health

Grant: UM1 CA186107

NCI NIH HHS

Grant: UM1 CA167552

NCI NIH HHS

Grant: P01 CA087969

NCI NIH HHS

Grant: P01 CA055075

NCI NIH HHS

Grant: R37 CA225655

National Institutes of Health

Grant: 5R01CA118553-04

Dietary and Lifestyle Determinants of Colon Cancer Recurrence and Survival

National Institutes of Health

Grant: 5UM1CA167552-02

Cancer Epidemiology Cohort in Male Health Professionals

National Institutes of Health

Grant: 5R01CA248857-04

Interdisciplinary Epidemiologic Consortium to Investigate T-cell Response in Colorectal Cancer

National Institutes of Health

Grant: 5R01CA137178-05

Inflammation and Colorectal Neoplasia

National Institutes of Health

Grant: 3P01CA087969-03S1

DIET, HORMONES AND RISK OF COLORECTAL CANCERS

National Institutes of Health

Grant: 1R01CA169141-01A1

Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer

National Institutes of Health

Grant: 3P01CA055075-10S1

PROSPECTIVE STUDY OF DIET AND CANCER IN MEN (HEALTH PROFESSIONALS FOLLOWUP)

National Institutes of Health

Grant: 5P50CA127003-12

Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer

National Institutes of Health

Grant: 5K24DK098311-03

Mentored Patient-Oriented Research in Digestive Diseases

National Institutes of Health

Grant: 5K07CA188126-02

Calcium and Colorectal Cancer: Gene-Environment Interactions and Molecular Pathways

National Institutes of Health

Grant: 5R35CA197735-06

Accelerating Transdisciplinary Epidemiology of Colorectal Cancer

National Institutes of Health

Grant: 5UM1CA186107-05

Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health Study

National Institutes of Health

Grant: 5R01CA151993-03

Epigenetic Events and Colorectal Cancer Epidemiology

Dana-Farber Cancer Institute

Gilead Sciences

Taiho Pharmaceutical

Bristol-Myers Squibb

Entertainment Industry Foundation

Gary Bennett Family Fund

Merck

Eli Lilly and Company

Japan Society for the Promotion of Science

Pfizer

Uehara Memorial Foundation

Colorectal Cancer Alliance

Conquer Cancer Foundation

George W. Stone Family Foundation

Mitsukoshi Health and Welfare Foundation

Bayer Corporation

Stand Up To Cancer

American Association for Cancer Research

Faculty of Arts and Sciences, Harvard University

FWCI

2.82

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.thelancet.com/article/S2352396420302358/pdf

publisherhttp://www.thelancet.com/article/S2352396420302358/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2352396420302358?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352396420302358?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ebiom.2020.102860

Fields of Study

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesColorectal Cancer Surgical Treatments03 medical and health sciences0302 clinical medicineAdultAgedCD3 ComplexCD4 AntigensCD8 AntigensColorectal NeoplasmsFemaleForkhead Transcription FactorsHumansLeukocyte Common AntigensLymphocytes, Tumor-InfiltratingMaleMiddle AgedNeoplasm InvasivenessT-Lymphocyte Subsets

MeSH Terms

AdultAgedFemaleHumansMaleMiddle AgedNeoplasm InvasivenessColorectal NeoplasmsCD4 AntigensT-Lymphocyte SubsetsLymphocytes, Tumor-InfiltratingCD8 AntigensCD3 ComplexLeukocyte Common AntigensForkhead Transcription Factors

Keywords

Colorectal cancerBuddingBiologyCancer researchCancerMedicineGeneticsArtificial intelligenceAdenocarcinomaClinical OutcomesEpithelial Mesenchymal TransitionMolecular Pathological EpidemiologyHost-tumour InteractionAdultMaleMedicine (General)Research paperCD3 ComplexCD8 Antigensartificial intelligence, clinical outcomesR5-920Lymphocytes, Tumor-InfiltratingT-Lymphocyte SubsetsHumansNeoplasm InvasivenessAgedRForkhead Transcription FactorsMiddle AgedCD4 AntigensLeukocyte Common AntigensFemaleColorectal Neoplasms

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being